Skip to main content

Table 3 Example of a summary of findings table that includes a separate row to show the absolute events for disadvantaged groups

From: Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration

Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Patient or population: Children aged between 6 months and five years
Intervention: Vitamin A supplementation
Comparison: Placebo or usual care
Outcomes Illustrative comparative risksa (95 % CI) Relative effect  (95 % CI) No. of Participants (studies) Quality of the evidence (GRADE) Comments
Diarrhoea-related mortality Low risk population RR 0.72; 95 % CI 0.57 to 0.91 90,951 (7 studies) +++O moderate2 Total number of participants reflects number randomised to studies. The analysis combined cumulative risk and risk per/1000 years follow-up.
3 per 10001 2 per 1000 (2 to 3)
Follow-up: 48–104 weeks Medium risk population
4 per 10001 3 per 1000 (2 to 4)
High risk population
9 per 10001 6 per 1000 (5 to 8)
  1. [94]